ACH
Accendra Health, Inc.
Price Chart
Latest Quote
$2.78
+0.13 (+4.90%)
Current Price
| Previous Close | $2.65 |
| Open | $2.68 |
| Day High | $2.85 |
| Day Low | $2.67 |
| Volume | 223,944 |
Stock Information
| Shares Outstanding | 76.58M |
| Total Debt | $2.17B |
| Cash Equivalents | $338.49M |
| Revenue | $2.72B |
| Net Income | $-105.34M |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Market Cap | $206.78M |
| EPS (TTM) | $-1.37 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $2.04B |
| Sales | $2.72B |
| Income | $-105.34M |
| Book/sh | $-6.07 |
| Cash/sh | $4.42 |
| Employees | 6K |
Financial Ratios
| Quick Ratio | 0.37 |
| Current Ratio | 0.49 |
Returns & Margins
| ROA | 1.55% |
| ROE | -198.35% |
| Gross Margin | 45.95% |
| Operating Margin | -1.02% |
| Profit Margin | -39.84% |
Ownership
| Insider Ownership | 7.71% |
| Institutional Ownership | 85.92% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 3.92 |
| PEG | 0.70 |
| P/S | 0.08 |
| P/B | -0.44 |
Analyst Data
| Recommendation | hold |
| Target Price | $4.49 |
Technical Indicators
| SMA20 | $2.92 |
| SMA50 | $3.03 |
| SMA200 | $3.31 |
| RSI | 41.73 |
| ATR | 0.2257 |
| Shares Float | 56.17M |
| Short Float | 9.43% |
| Short Ratio | 6.38 |
| Volatility | 1.62 |
| Rel Volume | 0.56 |
Performance History
| Week | -4.93% |
| Month | -26.83% |
| Quarter | +14.41% |
| 6 Months | +3.85% |
| YTD | +16.38% |
| Year | -59.46% |
| 3 Years | -86.71% |
| 5 Years | -93.96% |
| 10 Years | -91.92% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $2.70 | 543,062 |
| 2026-06-04 | $2.65 | 789,400 |
| 2026-06-03 | $2.58 | 745,700 |
| 2026-06-02 | $2.83 | 712,600 |
| 2026-06-01 | $2.77 | 681,200 |
| 2026-05-29 | $2.84 | 671,000 |
| 2026-05-28 | $2.89 | 638,800 |
| 2026-05-27 | $2.82 | 525,500 |
| 2026-05-26 | $2.76 | 906,700 |
| 2026-05-22 | $2.83 | 617,300 |
| 2026-05-21 | $2.71 | 551,500 |
| 2026-05-20 | $2.67 | 750,900 |
| 2026-05-19 | $2.80 | 904,300 |
| 2026-05-18 | $2.74 | 1,119,600 |
| 2026-05-15 | $2.91 | 818,400 |
| 2026-05-14 | $3.04 | 827,200 |
| 2026-05-13 | $3.15 | 1,427,800 |
| 2026-05-12 | $3.20 | 2,479,500 |
| 2026-05-11 | $3.89 | 2,799,600 |
| 2026-05-08 | $3.58 | 877,400 |
| 2026-05-07 | $3.74 | 660,200 |
| 2026-05-06 | $3.69 | 634,600 |
About Accendra Health, Inc.
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.
đ° Latest News
Are Options Traders Betting on a Big Move in Accendra Health Stock?
Zacks âĸ 2026-05-28T12:48:00Z
Accendra Health Inc (ACH) Q1 2026 Earnings Call Highlights: Navigating Revenue Declines and ...
GuruFocus.com âĸ 2026-05-12T07:02:59ZAccendra Health (ACH) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-11T17:38:59Z
Accendra Health (ACH) Shares Jump After First-Quarter Earnings Beat
InvestorsHub âĸ 2026-05-11T14:14:30Z
WAT Q1 Earnings Beat Estimates, BD Acquisition Aids Revenues
Zacks âĸ 2026-05-07T17:34:00Z
Is the Options Market Predicting a Spike in Accendra Health Stock?
Zacks âĸ 2026-03-13T12:30:00Z
Accendra Health (ACH) Reports 2025 Revenue of $2.8B and Shift Toward Core Home-Based Care
Insider Monkey âĸ 2026-02-24T14:32:43Z
Accendra Health Inc (ACH) Q4 2025 Earnings Call Highlights: Navigating Challenges and Strategic ...
GuruFocus.com âĸ 2026-02-20T05:02:12ZHenry Schein Leadership Exit Tests Distribution Strength And Competitive Position
Simply Wall St. âĸ 2026-02-08T18:03:53Z
Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Tuesday Trading
MT Newswires âĸ 2026-01-20T15:36:31Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,472,733,000 | $1,399,732,000 | $1,335,552,000 | $8,129,124,000 |
| Cost Of Revenue | $1,472,733,000 | $1,399,732,000 | $1,335,552,000 | $8,129,124,000 |
| Total Revenue | $2,762,032,000 | $2,680,112,000 | $2,552,572,000 | $9,955,475,000 |
| Operating Revenue | $2,762,032,000 | $2,680,112,000 | $2,552,572,000 | $9,955,475,000 |
| Expenses | ||||
| Interest Expense | $107,183,000 | $107,566,000 | $116,769,000 | $128,891,000 |
| Total Expenses | $2,540,293,000 | $2,482,076,000 | $2,337,208,000 | $9,678,693,000 |
| Other Income Expense | $-216,509,000 | $-420,355,000 | $-83,330,000 | $-137,000,000 |
| Other Non Operating Income Expenses | $-3,942,000 | $-4,589,000 | $-1,197,000 | $-3,131,000 |
| Net Non Operating Interest Income Expense | $-107,183,000 | $-107,566,000 | $-116,769,000 | $-128,891,000 |
| Interest Expense Non Operating | $107,183,000 | $107,566,000 | $116,769,000 | $128,891,000 |
| Operating Expense | $1,067,560,000 | $1,082,344,000 | $1,001,656,000 | $1,549,569,000 |
| Other Operating Expenses | - | $13,316,000 | $6,930,000 | $-5,252,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-102,682,000 | $-350,735,000 | $8,905,000 | $22,389,000 |
| Net Interest Income | $-107,183,000 | $-107,566,000 | $-116,769,000 | $-128,891,000 |
| Normalized Income | $65,245,930 | $-22,279,860 | $73,790,070 | $128,145,510 |
| Net Income From Continuing And Discontinued Operation | $-1,100,642,000 | $-362,686,000 | $-41,301,000 | $22,389,000 |
| Total Operating Income As Reported | $27,460,000 | $-217,730,000 | $133,231,000 | $142,913,000 |
| Net Income Common Stockholders | $-1,100,642,000 | $-362,686,000 | $-41,301,000 | $22,389,000 |
| Net Income | $-1,100,642,000 | $-362,686,000 | $-41,301,000 | $22,389,000 |
| Net Income Including Noncontrolling Interests | $-1,100,642,000 | $-362,686,000 | $-41,301,000 | $22,389,000 |
| Net Income Discontinuous Operations | $-997,960,000 | $-11,951,000 | $-50,206,000 | $0 |
| Net Income Continuous Operations | $-102,682,000 | $-350,735,000 | $8,905,000 | $22,389,000 |
| Pretax Income | $-101,953,000 | $-329,885,000 | $15,265,000 | $10,891,000 |
| Special Income Charges | $-212,567,000 | $-415,766,000 | $-82,133,000 | $-133,869,000 |
| Operating Income | $221,739,000 | $198,036,000 | $215,364,000 | $276,782,000 |
| Gross Profit | $1,289,299,000 | $1,280,380,000 | $1,217,020,000 | $1,826,351,000 |
| Per Share | ||||
| Diluted EPS | $-14.31 | $-4.73 | $-0.54 | $0.29 |
| Basic EPS | $-14.31 | $-4.73 | $-0.54 | $0.30 |
| Other | ||||
| Tax Effect Of Unusual Items | $-44,639,070 | $-87,310,860 | $-17,247,930 | $-28,112,490 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $432,321,000 | $374,728,000 | $424,538,000 | $502,318,000 |
| Total Unusual Items | $-212,567,000 | $-415,766,000 | $-82,133,000 | $-133,869,000 |
| Total Unusual Items Excluding Goodwill | $-212,567,000 | $-415,766,000 | $-82,133,000 | $-133,869,000 |
| Reconciled Depreciation | $214,524,000 | $181,281,000 | $210,371,000 | $228,667,000 |
| EBITDA (Bullshit earnings) | $219,754,000 | $-41,038,000 | $342,405,000 | $368,449,000 |
| EBIT | $5,230,000 | $-222,319,000 | $132,034,000 | $139,782,000 |
| Diluted Average Shares | $76,897,000 | $76,741,000 | $75,785,000 | $76,217,000 |
| Basic Average Shares | $76,897,000 | $76,741,000 | $75,785,000 | $74,496,000 |
| Diluted NI Availto Com Stockholders | $-1,100,642,000 | $-362,686,000 | $-41,301,000 | $22,389,000 |
| Tax Provision | $729,000 | $20,850,000 | $6,360,000 | $-11,498,000 |
| Impairment Of Capital Assets | $0 | $307,112,000 | $0 | $0 |
| Restructuring And Mergern Acquisition | $212,567,000 | $108,654,000 | $82,133,000 | $133,869,000 |
| Selling General And Administration | $1,067,560,000 | $1,082,344,000 | $1,001,656,000 | $1,554,821,000 |
| Other Special Charges | - | $1,101,000 | $-3,518,000 | - |
Fetched: 2026-05-30
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,825,583,000 | $-851,832,000 | $-1,076,515,000 | $-1,136,143,000 |
| Total Assets | $2,451,761,000 | $4,656,156,000 | $5,093,322,000 | $5,386,283,000 |
| Total Non Current Assets | $1,903,890,000 | $2,635,139,000 | $2,990,532,000 | $3,091,098,000 |
| Other Non Current Assets | $174,025,000 | $820,732,000 | $149,346,000 | $150,417,000 |
| Goodwill And Other Intangible Assets | $1,364,605,000 | $1,438,196,000 | $2,000,681,000 | $2,081,747,000 |
| Other Intangible Assets | $136,465,000 | $210,056,000 | $361,835,000 | $445,042,000 |
| Current Assets | $547,871,000 | $2,021,017,000 | $2,102,790,000 | $2,295,185,000 |
| Other Current Assets | $95,540,000 | $82,240,000 | $150,890,000 | $128,636,000 |
| Assets Held For Sale Current | $0 | $1,625,354,000 | - | - |
| Inventory | $74,435,000 | $67,581,000 | $1,110,606,000 | $1,333,585,000 |
| Receivables | $95,907,000 | $218,270,000 | $598,257,000 | $763,497,000 |
| Accounts Receivable | $95,907,000 | $218,270,000 | $598,257,000 | $763,497,000 |
| Allowance For Doubtful Accounts Receivable | $-7,678,000 | $-7,403,000 | $-7,900,000 | $-9,100,000 |
| Gross Accounts Receivable | $103,585,000 | $225,673,000 | $606,157,000 | $772,597,000 |
| Cash Cash Equivalents And Short Term Investments | $281,989,000 | $27,572,000 | $243,037,000 | $69,467,000 |
| Cash And Cash Equivalents | $281,989,000 | $27,572,000 | $243,037,000 | $69,467,000 |
| Debt | ||||
| Net Debt | $1,767,887,000 | $1,813,687,000 | $1,854,465,000 | $2,431,407,000 |
| Total Debt | $2,120,193,000 | $1,930,725,000 | $2,319,931,000 | $2,716,343,000 |
| Long Term Debt And Capital Lease Obligation | $1,870,193,000 | $1,887,859,000 | $2,113,027,000 | $2,698,437,000 |
| Long Term Debt | $1,799,876,000 | $1,798,393,000 | $1,890,598,000 | $2,482,968,000 |
| Current Debt And Capital Lease Obligation | $250,000,000 | $42,866,000 | $206,904,000 | $17,906,000 |
| Current Debt | $250,000,000 | $42,866,000 | $206,904,000 | $17,906,000 |
| Other Current Borrowings | - | $40,000,000 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,912,739,000 | $4,069,792,000 | $4,169,156,000 | $4,440,679,000 |
| Total Non Current Liabilities Net Minority Interest | $1,965,664,000 | $2,217,740,000 | $2,277,271,000 | $2,874,213,000 |
| Other Non Current Liabilities | $95,471,000 | $72,551,000 | $122,592,000 | $114,943,000 |
| Liabilities Heldfor Sale Non Current | $0 | $237,894,000 | - | - |
| Non Current Deferred Liabilities | $0 | $19,436,000 | $41,652,000 | $60,833,000 |
| Non Current Deferred Taxes Liabilities | $0 | $19,436,000 | $41,652,000 | $60,833,000 |
| Current Liabilities | $947,075,000 | $1,852,052,000 | $1,891,885,000 | $1,566,466,000 |
| Other Current Liabilities | $264,084,000 | $1,375,581,000 | $396,701,000 | $307,850,000 |
| Payables And Accrued Expenses | $432,991,000 | $433,605,000 | $1,288,280,000 | $1,240,710,000 |
| Payables | $363,565,000 | $359,927,000 | $1,171,882,000 | $1,147,414,000 |
| Accounts Payable | $363,565,000 | $359,927,000 | $1,171,882,000 | $1,147,414,000 |
| Equity | ||||
| Common Stock Equity | $-460,978,000 | $586,364,000 | $924,166,000 | $945,604,000 |
| Total Equity Gross Minority Interest | $-460,978,000 | $586,364,000 | $924,166,000 | $945,604,000 |
| Stockholders Equity | $-460,978,000 | $586,364,000 | $924,166,000 | $945,604,000 |
| Gains Losses Not Affecting Retained Earnings | $-885,000 | $-49,344,000 | $-31,818,000 | $-35,855,000 |
| Other Equity Adjustments | $-885,000 | $-49,344,000 | $-31,818,000 | $-35,855,000 |
| Retained Earnings | $-1,079,752,000 | $27,159,000 | $368,707,000 | $410,008,000 |
| Other | ||||
| Ordinary Shares Number | $76,388,000 | $77,199,000 | $76,546,000 | $76,279,000 |
| Share Issued | $76,388,000 | $77,199,000 | $76,546,000 | $76,279,000 |
| Tangible Book Value | $-1,825,583,000 | $-851,832,000 | $-1,076,515,000 | $-1,136,143,000 |
| Invested Capital | $1,588,898,000 | $2,427,623,000 | $3,021,668,000 | $3,446,478,000 |
| Working Capital | $-399,204,000 | $168,965,000 | $210,905,000 | $728,719,000 |
| Capital Lease Obligations | $70,317,000 | $89,466,000 | $222,429,000 | $215,469,000 |
| Total Capitalization | $1,338,898,000 | $2,384,757,000 | $2,814,764,000 | $3,428,572,000 |
| Additional Paid In Capital | $466,882,000 | $454,151,000 | $434,185,000 | $418,894,000 |
| Capital Stock | $152,777,000 | $154,398,000 | $153,092,000 | $152,557,000 |
| Common Stock | $152,777,000 | $154,398,000 | $153,092,000 | $152,557,000 |
| Long Term Capital Lease Obligation | $70,317,000 | $89,466,000 | $222,429,000 | $215,469,000 |
| Current Accrued Expenses | $69,426,000 | $73,678,000 | $116,398,000 | $93,296,000 |
| Goodwill | $1,228,140,000 | $1,228,140,000 | $1,638,846,000 | $1,636,705,000 |
| Net PPE | $365,260,000 | $376,211,000 | $840,505,000 | $858,934,000 |
| Accumulated Depreciation | $-207,595,000 | $-183,745,000 | $-546,397,000 | $-450,286,000 |
| Gross PPE | $572,855,000 | $559,956,000 | $1,386,902,000 | $1,309,220,000 |
| Other Properties | $559,333,000 | $536,001,000 | $658,725,000 | $604,672,000 |
| Buildings And Improvements | $13,522,000 | $23,955,000 | $201,939,000 | $197,228,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $74,435,000 | $67,581,000 | $1,051,553,000 | $1,333,585,000 |
| Current Capital Lease Obligation | - | $5,200,000 | - | - |
| Construction In Progress | - | $32,185,000 | $10,728,000 | $14,400,000 |
| Machinery Furniture Equipment | - | $472,590,000 | $492,551,000 | $470,071,000 |
| Land And Improvements | - | $9,376,000 | $22,959,000 | $22,849,000 |
| Inventories Adjustments Allowances | - | $-64,956,000 | $-78,185,000 | - |
| Work In Process | - | $59,115,000 | $61,527,000 | - |
| Raw Materials | - | $77,922,000 | $75,711,000 | - |
Fetched: 2026-05-30
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-303,115,000 | $-21,170,000 | $562,179,000 | $158,424,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-101,790,000 | $161,495,000 | $740,710,000 | $325,006,000 |
| Cash From Discontinued Operating Activities | $-256,286,000 | $17,809,000 | $404,252,000 | - |
| Cash Flow From Continuing Operating Activities | $154,496,000 | $143,686,000 | $336,458,000 | $325,006,000 |
| Operating Gains Losses | $-27,274,000 | $-34,254,000 | $-38,400,000 | $-26,260,000 |
| Investing Activities | ||||
| Capital Expenditure | $-201,325,000 | $-182,665,000 | $-178,531,000 | $-166,582,000 |
| Investing Cash Flow | $144,423,000 | $-116,533,000 | $-137,254,000 | $-1,804,476,000 |
| Cash From Discontinued Investing Activities | $-54,570,000 | $-18,497,000 | $-29,361,000 | - |
| Cash Flow From Continuing Investing Activities | $198,993,000 | $-98,036,000 | $-107,893,000 | $-1,804,476,000 |
| Net Other Investing Changes | $-1,910,000 | $14,703,000 | $-936,000 | $-1,670,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-10,179,000 | $0 | $0 | - |
| Financing Cash Flow | $188,078,000 | $-267,603,000 | $-417,330,000 | $1,497,105,000 |
| Cash From Discontinued Financing Activities | $-2,127,000 | $-17,580,000 | $-6,274,000 | - |
| Cash Flow From Continuing Financing Activities | $190,205,000 | $-250,023,000 | $-411,056,000 | $1,497,105,000 |
| Net Other Financing Charges | $-3,116,000 | $-5,826,000 | $5,637,000 | $-85,395,000 |
| Net Common Stock Issuance | $-10,179,000 | $0 | $0 | $0 |
| Cash Dividends Paid | - | - | $0 | $0 |
| Common Stock Dividend Paid | - | - | $0 | $0 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-2,711,284,000 | $-2,345,797,000 | $-892,693,000 | $-1,160,800,000 |
| Issuance Of Debt | $2,914,784,000 | $2,101,600,000 | $476,000,000 | $2,743,300,000 |
| Interest Paid Supplemental Data | $134,710,000 | $141,547,000 | $153,247,000 | $107,022,000 |
| Income Tax Paid Supplemental Data | $12,471,000 | $5,553,000 | $6,283,000 | $33,973,000 |
| End Cash Position | $281,989,000 | $49,382,000 | $272,924,000 | $86,185,000 |
| Beginning Cash Position | $49,382,000 | $272,924,000 | $86,185,000 | $72,035,000 |
| Effect Of Exchange Rate Changes | $1,896,000 | $-901,000 | $613,000 | $-3,485,000 |
| Changes In Cash | $230,711,000 | $-222,641,000 | $186,126,000 | $17,635,000 |
| Common Stock Payments | $-10,179,000 | $0 | $0 | - |
| Net Issuance Payments Of Debt | $203,500,000 | $-244,197,000 | $-416,693,000 | $1,582,500,000 |
| Net Long Term Debt Issuance | $203,500,000 | $-244,197,000 | $-416,693,000 | $1,582,500,000 |
| Long Term Debt Payments | $-2,711,284,000 | $-2,345,797,000 | $-892,693,000 | $-1,160,800,000 |
| Long Term Debt Issuance | $2,914,784,000 | $2,101,600,000 | $476,000,000 | $2,743,300,000 |
| Net Business Purchase And Sale | $324,260,000 | $0 | $0 | $-1,684,607,000 |
| Sale Of Business | $342,351,000 | $0 | $0 | $0 |
| Purchase Of Business | $-18,091,000 | $0 | $0 | $-1,684,607,000 |
| Net Intangibles Purchase And Sale | $-10,369,000 | $-12,379,000 | $-6,156,000 | $-8,492,000 |
| Purchase Of Intangibles | $-10,369,000 | $-12,379,000 | $-6,156,000 | $-8,492,000 |
| Net PPE Purchase And Sale | $-112,988,000 | $-100,360,000 | $-100,801,000 | $-109,707,000 |
| Sale Of PPE | $77,968,000 | $69,926,000 | $71,574,000 | $48,383,000 |
| Purchase Of PPE | $-190,956,000 | $-170,286,000 | $-172,375,000 | $-158,090,000 |
| Change In Working Capital | $65,208,000 | $22,600,000 | $137,434,000 | $93,083,000 |
| Change In Other Working Capital | $-56,779,000 | $-36,026,000 | $146,532,000 | $-91,544,000 |
| Change In Payables And Accrued Expense | $6,478,000 | $66,894,000 | $5,245,000 | $13,652,000 |
| Change In Payable | $6,478,000 | $66,894,000 | $5,245,000 | $13,652,000 |
| Change In Account Payable | $6,478,000 | $66,894,000 | $5,245,000 | $13,652,000 |
| Change In Inventory | $-6,854,000 | $-4,591,000 | $-5,352,000 | $166,559,000 |
| Change In Receivables | $122,363,000 | $-3,677,000 | $-8,991,000 | $4,416,000 |
| Changes In Account Receivables | $122,363,000 | $-3,677,000 | $-8,991,000 | $4,416,000 |
| Other Non Cash Items | $9,734,000 | $9,086,000 | $9,757,000 | $12,495,000 |
| Stock Based Compensation | $12,873,000 | $16,638,000 | $14,395,000 | $20,993,000 |
| Asset Impairment Charge | $0 | $307,112,000 | $0 | $0 |
| Deferred Tax | $-17,887,000 | $-8,042,000 | $-6,004,000 | $-26,361,000 |
| Deferred Income Tax | $-17,887,000 | $-8,042,000 | $-6,004,000 | $-26,361,000 |
| Depreciation Amortization Depletion | $214,524,000 | $181,281,000 | $210,371,000 | $228,667,000 |
| Depreciation And Amortization | $214,524,000 | $181,281,000 | $210,371,000 | $228,667,000 |
| Gain Loss On Sale Of PPE | $-27,274,000 | $-35,355,000 | $-34,882,000 | $-26,260,000 |
| Net Income From Continuing Operations | $-102,682,000 | $-350,735,000 | $8,905,000 | $22,389,000 |
| Proceeds From Stock Option Exercised | - | - | $0 | $0 |
| Net Short Term Debt Issuance | - | - | $0 | $30,000,000 |
| Provisionand Write Offof Assets | - | - | $-1,414,000 | $3,315,000 |
| Interest Paid Cff | - | - | - | $-42,602,000 |
| Gain Loss On Sale Of Business | - | - | - | $0 |
| Short Term Debt Payments | - | - | - | - |
Fetched: 2026-05-30